BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8011547)

  • 1. A second course of treatment for childhood acute lymphoblastic leukaemia: long-term follow-up is needed to assess results.
    Chessells JM; Leiper AD; Richards SM
    Br J Haematol; 1994 Jan; 86(1):48-54. PubMed ID: 8011547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association.
    Uderzo C; Valsecchi MG; Bacigalupo A; Meloni G; Messina C; Polchi P; Di Girolamo G; Dini G; Miniero R; Locatelli F
    J Clin Oncol; 1995 Feb; 13(2):352-8. PubMed ID: 7844596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
    Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X.
    Chessells JM; Bailey C; Wheeler K; Richards SM
    Lancet; 1992 Sep; 340(8819):565-8. PubMed ID: 1355153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular relapse of childhood acute lymphoblastic leukaemia.
    Somervaille TC; Hann IM; Harrison G; Eden TO; Gibson BE; Hill FG; Mitchell C; Kinsey SE; Vora AJ; Lilleyman JS;
    Br J Haematol; 2003 Apr; 121(2):280-8. PubMed ID: 12694250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia.
    Chessells JM; Veys P; Kempski H; Henley P; Leiper A; Webb D; Hann IM
    Br J Haematol; 2003 Nov; 123(3):396-405. PubMed ID: 14616997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose vincristine, fractionated total-body irradiation and cyclophosphamide as conditioning regimen in allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission: a 7-year Italian multicentre study.
    Uderzo C; Rondelli R; Dini G; Dallorso S; Messina C; Miniero R; Locatelli F; De Manzini A; Pession A; Balduzzi A
    Br J Haematol; 1995 Apr; 89(4):790-7. PubMed ID: 7772514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group.
    Borgmann A; Schmid H; Hartmann R; Baumgarten E; Hermann K; Klingebiel T; Ebell W; Zintl F; Gadner H; Henze G
    Lancet; 1995 Sep; 346(8979):873-6. PubMed ID: 7564672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia.
    Ribeiro RC; Rivera GK; Hudson M; Mulhern RK; Hancock ML; Kun L; Mahmoud H; Sandlund JT; Crist WM; Pui CH
    J Clin Oncol; 1995 Feb; 13(2):333-8. PubMed ID: 7844594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study.
    Bordigoni P; Esperou H; Souillet G; Pico J; Michel G; Lacour B; Reiffers J; Sadoun A; Rohrlich P; Jouet JP; Milpied N; Lutz P; Plouvier E; Cornu G; Vannier JP; Gandemer V; Rubie H; Gratecos N; Leverger G; Stephan JL; Boutard P; Vernant JP
    Br J Haematol; 1998 Aug; 102(3):656-65. PubMed ID: 9722290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
    Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
    Borgmann A; Hartmann R; Schmid H; Klingebiel T; Ebell W; Göbel U; Peters C; Gadner H; Henze G
    Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation for acute lymphoblastic leukaemia.
    Barrett AJ
    Baillieres Clin Haematol; 1994 Jun; 7(2):377-401. PubMed ID: 7803908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study.
    Boulad F; Steinherz P; Reyes B; Heller G; Gillio AP; Small TN; Brochstein JA; Kernan NA; O'Reilly RJ
    J Clin Oncol; 1999 Jan; 17(1):197-207. PubMed ID: 10458234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation versus chemotherapy for childhood acute lymphoblastic leukaemia in second remission.
    Bacigalupo A; Van Lint MT; Frassoni F; Occhini D; Pittaluga PA; Comelli A; Dini G; Massimo L; Marmont AM
    Bone Marrow Transplant; 1986 May; 1(1):75-80. PubMed ID: 3332122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research.
    Eapen M; Zhang MJ; Devidas M; Raetz E; Barredo JC; Ritchey AK; Godder K; Grupp S; Lewis VA; Malloy K; Carroll WL; Davies SM; Camitta BM; ;
    Leukemia; 2008 Feb; 22(2):281-6. PubMed ID: 18033318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.
    Wheeler K; Chessells JM; Bailey CC; Richards SM
    Arch Dis Child; 1996 Feb; 74(2):101-7. PubMed ID: 8660070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.
    Barrett AJ; Horowitz MM; Pollock BH; Zhang MJ; Bortin MM; Buchanan GR; Camitta BM; Ochs J; Graham-Pole J; Rowlings PA
    N Engl J Med; 1994 Nov; 331(19):1253-8. PubMed ID: 7935682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.